• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

25-羟维生素 D 水平与慢性肝病患者肝损伤和死亡的相关性研究。

Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease.

机构信息

Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz,, Graz, Austria.

出版信息

Liver Int. 2012 May;32(5):845-51. doi: 10.1111/j.1478-3231.2011.02735.x. Epub 2012 Jan 4.

DOI:10.1111/j.1478-3231.2011.02735.x
PMID:22222013
Abstract

BACKGROUND

Previous studies suggest that chronic liver disease may be related to vitamin D deficiency. It is, however, not known whether 25(OH)D levels are associated with incident hepatic decompensation and mortality in chronic liver failure.

AIMS

We aimed to evaluate whether 25(OH)D serum levels are associated with Child-Pugh (CP) score, model for end-stage liver disease (MELD) score, occurrence of hepatic decompensation, and survival in patients with cirrhosis.

METHODS

We enrolled 75 consecutive cirrhotic patients admitted to our outpatient liver clinic (32% females; age: 58 ± 11 years; aetiology alcohol in 61%). At baseline, 25(OH)D was determined and the degree of liver dysfunction was estimated by CP and MELD score. Thereafter patients were followed-up with respect to hepatic decompensation and mortality.

RESULTS

25(OH)D levels averaged 16.0 ± 9.2 ng/ml and were inversely correlated with MELD score (r = -0.34, P = 0.003) and CP score (r = -0.21, P = 0.080). Thirty-seven patients developed hepatic decompensation and 24 patients died during a median follow-up of 3.6 years. Age- and gender-adjusted relative risk (with 95% confidence interval) was 6.37 (1.75-23.2; P = 0.005) for hepatic decompensation and 4.31 (1.38-13.5; P = 0.012) for mortality within the first vs the third 25(OH)D tertile but these associations were largely attenuated towards non-significant trends after additional adjustments for CP or MELD score.

CONCLUSIONS

Our findings show a significant association of 25(OH)D with the degree of liver dysfunction and suggest that low 25(OH)D levels may predict hepatic decompensation and mortality in patients with chronic liver failure.

摘要

背景

先前的研究表明,慢性肝病可能与维生素 D 缺乏有关。然而,慢性肝衰竭患者 25(OH)D 水平是否与肝性失代偿和死亡率有关尚不清楚。

目的

我们旨在评估 25(OH)D 血清水平是否与慢性肝衰竭患者的 Child-Pugh (CP)评分、终末期肝病模型 (MELD)评分、肝性失代偿的发生和生存率相关。

方法

我们纳入了 75 例连续就诊于我们门诊肝脏诊所的肝硬化患者(32%为女性;年龄:58 ± 11 岁;病因:酒精 61%)。基线时,测定 25(OH)D 水平,并通过 CP 和 MELD 评分评估肝功能不全程度。随后,对患者进行肝性失代偿和死亡率的随访。

结果

25(OH)D 水平平均为 16.0 ± 9.2ng/ml,与 MELD 评分(r = -0.34,P = 0.003)和 CP 评分(r = -0.21,P = 0.080)呈负相关。37 例患者发生肝性失代偿,24 例患者在中位随访 3.6 年后死亡。年龄和性别调整后的相对风险(95%置信区间)为 6.37(1.75-23.2;P = 0.005)肝性失代偿和 4.31(1.38-13.5;P = 0.012)死亡率在第一个与第三个 25(OH)D 三分位组之间,但这些关联在进一步调整 CP 或 MELD 评分后,大多呈非显著趋势。

结论

我们的发现表明 25(OH)D 与肝功能障碍程度显著相关,并表明慢性肝衰竭患者 25(OH)D 水平低可能预测肝性失代偿和死亡率。

相似文献

1
Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease.25-羟维生素 D 水平与慢性肝病患者肝损伤和死亡的相关性研究。
Liver Int. 2012 May;32(5):845-51. doi: 10.1111/j.1478-3231.2011.02735.x. Epub 2012 Jan 4.
2
Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis.低25-羟基维生素D水平反映肝功能障碍,并与肝硬化患者的死亡率相关。
Wien Klin Wochenschr. 2017 Jan;129(1-2):8-15. doi: 10.1007/s00508-016-1127-1. Epub 2016 Nov 25.
3
Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.慢性肝衰竭联盟急性加重慢性肝衰竭和急性失代偿评分可预测巴西肝硬化患者的死亡率。
World J Gastroenterol. 2017 Jul 28;23(28):5237-5245. doi: 10.3748/wjg.v23.i28.5237.
4
Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: A prospective cohort study.维生素 D 缺乏与肝硬化患者肝失代偿和炎症相关:一项前瞻性队列研究。
PLoS One. 2018 Nov 8;13(11):e0207162. doi: 10.1371/journal.pone.0207162. eCollection 2018.
5
Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.维生素 D 缺乏与酒精性肝病患者预后不良相关。
J Hepatol. 2013 Aug;59(2):344-50. doi: 10.1016/j.jhep.2013.03.024. Epub 2013 Apr 1.
6
Vitamin D Deficiency Is Highly Prevalent in Critically Ill Patients and a Risk Factor for Mortality: A Prospective Observational Study Comparing Noncirrhotic Patients and Patients With Cirrhosis.维生素 D 缺乏在危重症患者中极为普遍,是死亡的危险因素:一项比较非肝硬化患者和肝硬化患者的前瞻性观察研究。
J Intensive Care Med. 2020 Oct;35(10):992-1001. doi: 10.1177/0885066618803844. Epub 2018 Oct 1.
7
Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation.等待肝移植且血清肌酐正常的终末期肝病患者中的维生素D缺乏、甲状旁腺激素水平与骨病
Clin Transplant. 2014 May;28(5):579-84. doi: 10.1111/ctr.12351. Epub 2014 Apr 21.
8
Hepatic Decompensation in Patients with Chronic Liver Disease: Exploring the Role of Vitamin D Deficiency as a Prognostic Marker.慢性肝病患者的肝代偿失调:探讨维生素 D 缺乏作为预后标志物的作用。
J Assoc Physicians India. 2024 Mar;72(3):82-86. doi: 10.59556/japi.72.0352.
9
Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis.低25-羟维生素D水平与肝硬化患者的感染及死亡率相关。
PLoS One. 2015 Jun 29;10(6):e0132119. doi: 10.1371/journal.pone.0132119. eCollection 2015.
10
Association of low serum 25-Hydroxy vitamin D [25(OH) d] with hepatic encephalopathy in patients with decompensated liver cirrhosis.血清 25-羟维生素 D [25(OH)d] 水平降低与肝硬化失代偿期患者肝性脑病的关系。
Arab J Gastroenterol. 2024 May;25(2):182-187. doi: 10.1016/j.ajg.2024.01.014. Epub 2024 Mar 8.

引用本文的文献

1
Effects of vitamin D supplementation on the glycaemic indices, lipid profile and liver function tests in patients with cirrhosis: a double-blind randomised controlled trial.补充维生素D对肝硬化患者血糖指数、血脂谱及肝功能检查的影响:一项双盲随机对照试验。
BMJ Nutr Prev Health. 2024 Aug 30;7(2):e000938. doi: 10.1136/bmjnph-2024-000938. eCollection 2024.
2
The Role of Vitamin D Deficiency in Hepatic Encephalopathy: A Review of Pathophysiology, Clinical Outcomes, and Therapeutic Potential.维生素D缺乏在肝性脑病中的作用:病理生理学、临床结局及治疗潜力综述
Nutrients. 2024 Nov 23;16(23):4007. doi: 10.3390/nu16234007.
3
Modeling calcium and magnesium balance: Regulation by calciotropic hormones and adaptations under varying dietary intake.
钙和镁平衡建模:钙调节激素的调节作用及不同饮食摄入情况下的适应性变化
iScience. 2024 Sep 30;27(11):111077. doi: 10.1016/j.isci.2024.111077. eCollection 2024 Nov 15.
4
Association between serum vitamin D status and severity of liver cirrhosis: implications for therapeutic targeting in Nigerian patients.血清维生素 D 状况与肝硬化严重程度的关系:对尼日利亚患者治疗靶点的启示。
BMC Gastroenterol. 2024 Aug 12;24(1):259. doi: 10.1186/s12876-024-03353-1.
5
Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights.维生素 D 与代谢相关脂肪性肝病(MASLD):新的机制见解。
Int J Mol Sci. 2024 Apr 30;25(9):4901. doi: 10.3390/ijms25094901.
6
Pathophysiological-Based Nutritional Interventions in Cirrhotic Patients with Sarcopenic Obesity: A State-of-the-Art Narrative Review.基于病理生理学的营养干预在伴有肌肉减少症的肝硬化患者中的应用:最新的叙述性综述。
Nutrients. 2024 Jan 31;16(3):427. doi: 10.3390/nu16030427.
7
Association of chronic liver disease with bone diseases and muscle weakness.慢性肝病与骨骼疾病和肌肉无力的关联。
J Bone Miner Metab. 2024 Jul;42(4):399-412. doi: 10.1007/s00774-023-01488-x. Epub 2024 Feb 1.
8
Vitamin D status & bone health in patients with liver cirrhosis.维生素 D 状态与肝硬化患者的骨骼健康。
Indian J Med Res. 2023 Sep;158(3):284-291. doi: 10.4103/ijmr.IJMR_1144_20.
9
The effects of vitamin D on all-cause mortality in different diseases: an evidence-map and umbrella review of 116 randomized controlled trials.维生素D对不同疾病全因死亡率的影响:116项随机对照试验的证据图谱与综合评价
Front Nutr. 2023 Jun 22;10:1132528. doi: 10.3389/fnut.2023.1132528. eCollection 2023.
10
Prognostic significance of sarcopenia and severe vitamin D deficiency in patients with cirrhosis.肝硬化患者肌肉减少症和严重维生素D缺乏的预后意义
JGH Open. 2023 Apr 14;7(5):351-357. doi: 10.1002/jgh3.12900. eCollection 2023 May.